Figure 1
ATG in cord blood transplants does not influence EFS and engraftment but does lead to more aGVHD. Kaplan-Meier survival curve and Cox proportional hazards analysis of the (A) probability of EFS, (B) probability of neutrophil engraftment: neutrophil count of 0.5 × 109/L for at least 3 days in the first 60 days after stem cell transplant (SCT), (C) probability of aGVHD grade II to IV, and (D) probability of cGVHD. P < .05 is considered significant. Patients represented as having received no ATG, received ATG early, or received ATG late. NS, nonsignificant.

ATG in cord blood transplants does not influence EFS and engraftment but does lead to more aGVHD. Kaplan-Meier survival curve and Cox proportional hazards analysis of the (A) probability of EFS, (B) probability of neutrophil engraftment: neutrophil count of 0.5 × 109/L for at least 3 days in the first 60 days after stem cell transplant (SCT), (C) probability of aGVHD grade II to IV, and (D) probability of cGVHD. P < .05 is considered significant. Patients represented as having received no ATG, received ATG early, or received ATG late. NS, nonsignificant.

Close Modal

or Create an Account

Close Modal
Close Modal